Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Complications of atherosclerosis are the most common cause of death in Western societies. Among the many risk factors identified by epidemiological studies, only elevated levels of lipoproteins containing apolipoprotein (apo) B can drive the development of atherosclerosis in humans and experimental animals even in the absence of other risk factors. However, the mechanisms that lead to atherosclerosis are still poorly understood. We tested the hypothesis that the subendothelial retention of atherogenic apoB-containing lipoproteins is the initiating event in atherogenesis. The extracellular matrix of the subendothelium, particularly proteoglycans, is thought to play a major role in the retention of atherogenic lipoproteins. The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycans. Here we present direct experimental evidence that the atherogenicity of apoB-containing low-density lipoproteins (LDL) is linked to their affinity for artery wall proteoglycans. Mice expressing proteoglycan-binding-defective LDL developed significantly less atherosclerosis than mice expressing wild-type control LDL. We conclude that subendothelial retention of apoB100-containing lipoprotein is an early step in atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated concentration of low-density lipoprotein enhances its retention under the arterial wall(17); retention and oxidation of low-density lipoprotein are fundamental events in atherogenesis.(18)”
From Endometriosis and Risk of Coronary Heart Disease (2016) · cites this paper as [18]
In the citing paper
“The ECM has a central role in initiation of atherosclerosis, primarily through the interaction between the negatively charged side chains of proteoglycans (particularly chondroitin sulphate of biglycan and versican and heparin sulphate of perlecan 110 ) with positively charged apolipoproteins (especially apolipoprotein B) , which leads to the retention of plasma-derived lipoproteins 101,111 - as”
From Vascular smooth muscle cells in atherosclerosis (2019) · cites this paper as [101]
In the citing paper
“the interaction of apoB-containing lipoproteins (the non-HDL lipoproteins) with intimal extracellular proteoglycans (referred to as retention)1,43,44 inhibits the movement of the lipoproteins, thereby resulting in much higher subendothelial concentrations of these lipoproteins in the intima than in any other tissue45.”
From Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities (2019) · cites this paper as [44]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Glass, C. K., & Witztum, J. L. (2001) · Cell · doi:10.1016/s0092-8674(01)00238-0 · Cited by 3,051
Efficient Trace-labelling of Proteins with Iodine
McFARLANE, A. S. (1958) · Nature · doi:10.1038/182053a0 · Cited by 2,543
A simple fluorometric assay for lipoperoxide in blood plasma
Yagi, K. (1976) · Biochemical Medicine · doi:10.1016/0006-2944(76)90049-1 · Cited by 2,103 · cited 1×
“The concentrations of thiobarbituric-acid-reactive substance”
The Response-to-Retention Hypothesis of Early Atherogenesis
Williams, K. J., & Tabas, I. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.5.551 · Cited by 1,413
Cell Biology of Atherosclerosis
Ross, R. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.004043 · Cited by 1,003 · cited 1×
“gif" NDATA ITEM> ]> Complications of atherosclerosis are the most common cause of death in Western societie”
BackgroundTangirala, R. K., Rubin, E. M., & Palinski, W. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39713-3 · Cited by 514
Mahley, R. W., Innerarity, T. L., Pitas, R. E., Weisgraber, K. H., Brown, J. H., & Gross, E. (1977) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)66966-8 · Cited by 383
Self-citationBorén, J., Olin, K., Lee, I., Chait, A., Wight, T. N., & Innerarity, T. L. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2265 · Cited by 320 · cited 1×
“The interaction between atherogenic lipoproteins and proteoglycans involves an ionic interaction between basic amino acids in apoB100 and negatively charged sulphate groups on the proteoglycan”
BackgroundSelf-citationImmunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti, A., Kaveri, S., Caligiuri, G., Bariéty, J., & Hansson, G. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci119892 · Cited by 301
Cited by
Items 701–800 of 1,000
Reduced expression of KCNMB1 leads to vascular smooth muscle cell phenotypic switch and apoptosis
Liu, H., Zhou, X., Zhang, J., Zuo, B., Wang, G., Guo, Z., Zhang, J., Huang, H., Wang, W., & Wang, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117151 · Cited by 4
Biglycan: Unpuzzling the causal links between tobacco-smoking and atherosclerosis?
Baumgartner, R. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2014.08.057 · Cited by 4
Bogdanov, L. A., Velikanova, E. A., Shishkova, D. K., Рашитович, Ш. А., & Kutikhin, A. G. (2020) · Zhurnal «Patologicheskaia fiziologiia i eksperimental`naia terapiia» · doi:10.25557/0031-2991.2020.04.20-30 · Cited by 4
Pathogenesis of Atherosclerosis
Shah, P. K. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-918-9_22 · Cited by 4
Khamis, R., Hartley, A., Caga‐Anan, M., Pandey, S. S., Marceddu, C., Kojima, C., Chang, S., Boyle, J. J., Johnson, J. L., Björkbacka, H., et al. (2022) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2022.02.023 · Cited by 4
Babaahmadi‐Rezaei, H., Kheirollah, A., Rashidi, M., Seif, F., Niknam, Z., & Zamanpour, M. (2021) · PubMed Central · doi:10.22074/cellj.2021.7392 · Cited by 4
Youssef, K., & Woo, P.-Y. (2008) · InTech eBooks · doi:10.5772/6403 · Cited by 4
Are Novel Serum Biomarkers Informative?
Wilkins, J. T., & Lloyd‐Jones, D. M. (2012) · Medical Clinics of North America · doi:10.1016/j.mcna.2012.01.017 · Cited by 5
Tkáčová, R., Rizzo, M., & Berneis, K. K. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.03.031 · Cited by 6
“Retention, oxidation, and accumulation of oxidized LDL are an early phenomenon in the process of atherogenesis [31].”
BackgroundNeuroophthalmologic Disease of the Retina
Rizzo, J. F. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50283-6 · Cited by 4
Neuroophthalmologic Disease of the Retina
Fortin, É., & Rizzo, J. F. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_40 · Cited by 4
Fogelstrand, P., & Borén, J. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.306798 · Cited by 4
Self-citationGenetic influences on macrophage function and lipid uptake in atherosclerosis
O’Callaghan, C. A., & Jiang, J. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000986 · Cited by 3
Hu, F., Wu, R., Zhao, X., Zhao, Y.-K., Zhou, J., Hu, B., Li, A., & Sun, Y. (2025) · Translational Stroke Research · doi:10.1007/s12975-025-01367-9 · Cited by 3
“Lipoproteins rich in cholesterol and ApoB are retained and accumulate in the intima of the artery wall [24, 25], leading to the immune response and inflammatory mechanism that promote the formation and development of atherosclerotic plaques [26].”
Lyu, L., Kao, C., Su, J., Yu, Y., Zhang, X., Lyu, J., Che, J., & Zhang, J. (2026) · Lipids in Health and Disease · doi:10.1186/s12944-025-02852-8 · Cited by 4
“From a pathophysiological perspective, the accumulation of apoB-containing lipoproteins in the arterial intima is a key initiating event in atherogenesis [6–8].”
Mechanisms and therapeutic potential of colchicine in atherosclerotic cardiovascular disease
Xia, X., Yang, F., Liao, Y., Zhang, J., He, J., Yu, M., & Cheng, X. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00807-5 · Cited by 4
“https://doi.org/10.1038/s44161-026-00807-5 proteoglycans and glycosaminoglycans such as biglycan, versican, perlecan and hyaluronic acid, which bind circulating low-density lipoprotein (LDL) particles and promote their retention in the arterial intima 88,89 .”
InfluentialCentury of Progress on the Structure of APOB-100 in Atherogenic Lipoproteins
Coleman, B., Woollett, L. A., & Davidson, W. S. (2026) · Circulation Research · doi:10.1161/circresaha.126.328575 · Cited by 3
Investigation on the risk factors for late-onset OHSS: a retrospective case–control study
Xu, H., Yang, S., Cui, L., Feng, G., Li, R., & Qiao, J. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06182-9 · Cited by 3
Zhang, Y., Li, Y., Han, Z., Huo, Q., Ji, L., Liu, X., Li, H., Zhu, X., & Hao, Z. (2024) · BMB Reports · doi:10.5483/bmbrep.2024-0055 · Cited by 3
Dai, L., Lyu, L., Zhan, W.-Y., Jiang, S., & Zhou, P. (2025) · World Neurosurgery · doi:10.1016/j.wneu.2024.123649 · Cited by 3
A Bibliometric Analysis of Strategies for Atherosclerosis Treatment with Organic Nanoparticles
Ma, J., Zhao, X., Xu, X., Lixin, A., Liu, Q., & Qu, P. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17091131 · Cited by 3
“Proteoglycans like heparan sulfate and hyaluronic acid (HA) promote lipid retention and oxidative stress by electrostatically adsorbing low-density lipoprotein (LDL), accelerating lipid core formation [83,84].”
Atherosclerotic Plaque Imaging
Lavín, B., Gebhardt, P., Phinikaridou, A., & Botnar, R. M. (2017) · Springer eBooks · doi:10.1007/978-3-319-53001-7_8 · Cited by 3
Genetics and molecular biology
Ikonen, E. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200304000-00015 · Cited by 3
Cabiati, M., Giacomarra, M., Fontanini, M., Cecchettini, A., Pelosi, G., Vozzi, F., & Ry, S. D. (2022) · Heart and Vessels · doi:10.1007/s00380-022-02140-w · Cited by 3
“The importance and the role of the chronic inflammatory process are widely recognized, which, acting on the arteries, causes local endothelial activation and leads to the deposition of lipoproteins and cholesterol in the intima, representing the initial events of the pathological process [29, 30].”
BackgroundMolecular Pathomechanisms of Crystal-Induced Disorders
Shi, C., Mulay, S. R., Steiger, S., & Anders, H. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-41192-2_16 · Cited by 3
Progress of Fluorescent Probes for Protein Phosphorylation and Glycosylation in Atherosclerosis
Li, J., Xu, J., Zhao, R., Zhang, W., Li, P., Zhang, W., Wang, H., & Tang, B. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202303778 · Cited by 3
A novel assay to measure low-density lipoproteins binding to proteoglycans
Geh, E. N., Swertfeger, D. K., Sexmith, H., Heink, A., Tarapore, P., Melchior, J., Davidson, W. S., & SHAH, A. S. (2024) · PLoS ONE · doi:10.1371/journal.pone.0291632 · Cited by 3
“This model suggests that the binding of LDL to ECM-PGs is a key step in the development of atherosclerosis [1–3].”
Macrophages and Atherosclerosis
Newby, A. C. (2011) · Springer eBooks · doi:10.1007/978-3-7091-0338-8_17 · Cited by 4
Immune regulation in atherosclerosis and the hygiene hypothesis
Ait‐Oufella, H., Tedgui, A., & Mallat, Z. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8903-1_12 · Cited by 3
“Initially, lipoproteins infiltrate the artery wall to an extent that exceeds the capacity for elimination, and are retained in the intimal space [ 3 ].”
BackgroundLi, K., Liu, M., Yang, X., Chen, L., Geng, H. Z., Luo, W., & Ma, J. (2021) · Medicine · doi:10.1097/md.0000000000026340 · Cited by 3
“The continuous retaining and accumulation of particles containing cholesterol-abundant apolipoprotein B in the arterial intima triggers atherogenesis.([5,6]) Reportedly, atherosclerosis is identified as an inflammatory condition, and prevailing illnesses (i.”
BackgroundWang, H., Zhang, P., Chen, X., Liú, W., Fu, Z., & Liu, M. (2021) · Steroids · doi:10.1016/j.steroids.2021.108887 · Cited by 3
Apoptosis, Annexin A5 and Anti-Annexin A5 Antibodies in The Antiphospholipid Syndrome
Bećarević, M. B., Svetlana, I., & Nada, M.-S. (2013) · Journal of Medical Biochemistry · doi:10.2478/jomb-2013-0014 · Cited by 3
“In addition, annexin A5 binds to proteoglycans in the arterial wall and this might be an important early step in atherogenesis (45).”
BackgroundEndothelial and Vascular Smooth Cell Dysfunctions: A Comprehensive Appraisal
Rodella, L. F., & Rezzani, R. (2012) · InTech eBooks · doi:10.5772/25479 · Cited by 3
“This retention sequesters lipoproteins within the intimal, isolating them from plasma antioxidants, thus favoring their oxidative modification (Kruth, 2002; Packard & Libby, 2008; Skålen et al., 2002).”
BackgroundJiménez, J. (2012) · The Open Clinical Chemistry Journal · doi:10.2174/1874241601205010027 · Cited by 3
“The ceramide increase in lipoproteins promotes their aggregation while also promoting their retention in the atherosclerotic lesions leading to the formation of foam cells [21,22]; the sphingomyielinase activity is promoted by atherogenic inflammatory cytokines [23].”
Role of Lipoprotein-Associated Phospholipase A2 in Vascular Disease
Packard, C. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50018-4 · Cited by 3
Fernandes, A. S., Providencia, R. A., Reis, F., & Gonçalves, L. M. M. (2015) · Springer eBooks · doi:10.1007/978-3-319-16018-4_2 · Cited by 3
Nigro, J., Ballinger, M. L., Survase, S., Osman, N., & Little, P. J. (2005) · The Scientific World JOURNAL · doi:10.1100/tsw.2005.69 · Cited by 3
“Modifying the ionic charges by altering the amino acids in the apoB100 molecule on LDL in a murine transgenic model, which prevents the binding of LDL to proteoglycans, greatly attenuates the development of atherosclerosis[8].”
Effects of Polyphenol-Rich Foods on Human Health
Grosso, G. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-143-6 · Cited by 8
Endothelial Activation and the Initiation of Atherosclerosis
Caterina, R. D., Zampolli, A., Lazzerini, G., & Libby, P. (2007) · Wiley eBooks · doi:10.1002/9780470988473.ch2 · Cited by 3
Potential Health Benefits of Blackcurrants
Miller, R. J., Putnam, S. E., Edwards, M., Woodward, G., & Kay, C. D. (2013) · Wiley eBooks · doi:10.1002/9781118635551.ch10 · Cited by 5
Macrophage Foam Cell Formation: The Pathways to Cholesterol Engorgement
Moore, K. J., & Rayner, K. J. (2010) · Wiley eBooks · doi:10.1002/9783527629589.ch12 · Cited by 6
Immunomodulation and its effector mechanisms in atherosclerosis
Hjerpe, C. (2007) · Figshare · Cited by 3
Alcohol, Inflammation, and Coronary Heart Disease
Imhof, A., & Köenig, W. (2003) · CRC Press eBooks · doi:10.1201/9780203507636.ch7 · Cited by 3
Nuevos conceptos fisiopatológicos y diagnósticos en los síndromes coronarios agudos
Velázquez, C. R., Nuevo, J. J. L., & Guerra, A. F. R. (2004) · Medicina Interna de México · Cited by 3
Standardization and quantification is a key to the future of atherosclerosis FDG PET/CT imaging
Pucar, D., & Liu, C. (2019) · Journal of Nuclear Cardiology · doi:10.1007/s12350-019-01905-7 · Cited by 3
Lian, H., Zhao, Z., Ma, K., Ding, Z., Sun, L., & Zhang, Y. (2022) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296221139258 · Cited by 2
Jin, M., Zhou, Y., Zhao, X., Liu, C., Liu, Z., Liu, S., & Zhenyan, F. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05502-8 · Cited by 2
“The lipids in these retained lipoproteins are engulfed by macrophages, initiating a cascade of inflammatory responses that drive the development and progression of atherosclerosis [43–47].”
Environmental Factors and Lipid Metabolism in Atherosclerosis Development
Caga‐Anan, M., Dasanayaka, N. N., & Seneviratne, A. N. (2026) · Lipidology · doi:10.3390/lipidology3010007 · Cited by 2
Are we underestimating the benefits of lipid-lowering therapies?
Pirillo, A., Casula, M., Olmastroni, E., Scotti, S., Corsini, A., & Catapano, A. L. (2026) · Pharmacological Reviews · doi:10.1016/j.pharmr.2026.100140 · Cited by 2
Vascular smooth muscle cell mechanotransduction: Pathways, phenotypes and emerging technologies
Lakshminaraasimulu, N. K., Smyth, R., Prakash, A., & Iskratsch, T. (2026) · The Journal of Physiology · doi:10.1113/jp290371 · Cited by 4
Phospholipase A2: An emerging biomarker in vascular diseases
Jain, K., Vadak, N., & Bhatt, L. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-15313-6.00002-8 · Cited by 2
Jaliliyan, A., Madankan, A., Mosavari, H., Khalili, P., Pouraskari, A. B., Lotfi, S., Honarfar, A., Fakhri, E., & Eghbali, F. (2024) · Obesity Surgery · doi:10.1007/s11695-024-07258-6 · Cited by 3
“The binding of Apo-B100 to arterial wall proteoglycans triggers the retention and accumulation of LDL particles in the subendothelial space [17, 18].”
Papel de los lípidos en la ateroesclerosis
Civeira, F., Marco-Benedí, V., & Cenarro, A. (2020) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(20)30023-6 · Cited by 9
Atherosclerosis in Cardiovascular Disease: An Overview
Ta, Q. V. (2021) · doi:10.53901/xile9qd949e · Cited by 2
Calcific Aortic Stenosis: Pathology and Role of Balloon Aortic Valvuloplasty
Baber, U., Kini, A. S., Moreno, P., & Sharma, S. K. (2011) · Interventional Cardiology Clinics · doi:10.1016/j.iccl.2011.09.001 · Cited by 2
Lipides peroxydés et réaction immuno-inflammatoire dans l’athérosclérose
Nalbone, G., Peiretti, F., Canault, M., & Alessi, M. (2006) · Oléagineux Corps gras Lipides · doi:10.1051/ocl.2006.0044 · Cited by 2
“Elle débute par des dépôts de lipides pariétaux provenant de l’infiltration de lipoprotéines athérogènes [15], majoritairement les LDL qui se lient aux protéoglycanes de la matrice extracellulaire du sous-endothélium.”
BackgroundUltrasound Evaluation of Carotid Intima Media Thickness: The Hows and Whys
Latich, I., & Scoutt, L. M. (2011) · Ultrasound Clinics · doi:10.1016/j.cult.2011.08.002 · Cited by 2
Neoatherosclerosis: a novel player in late stent failure
Montone, R. A., Mirizzi, A. M., & Niccoli, G. (2014) · Interventional Cardiology · doi:10.2217/ica.14.15 · Cited by 2
Vascular Biology of the Metabolic Syndrome
Lee, J., & Choudhury, R. P. (2006) · CRC Press eBooks · doi:10.3109/9781420020601-5 · Cited by 2
Rippe, J. M., & Angelopoulos, T. J. (2012) · CRC Press eBooks · doi:10.1201/b12085-15 · Cited by 2
Nuñez, C. E. C., Oliveira, J. B., de Barros-Mazon, S., Zago, V. H. D. S., Kaplan, D., Nakamura, R. T., Gidlund, M., Gomes, É. I. L., Cazita, P. M., Nakandakare, E. R., et al. (2022) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20210796 · Cited by 2
Pathology of Drug-Eluting Stents in Humans
Otsuka, F., Nakano, M., Kolodgie, F. D., Virmani, R., & Finn, A. V. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-0764-5.00005-8 · Cited by 2
Munro, J. M., & Path, F. R. C. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.07.013 · Cited by 2
“An early event in atherosclerosis appears to be the accumulation of apolipoprotein B, via binding to vascular proteoglycans, based on studies in transgenic mice [6].”
BackgroundUca, Y. O., & Taupitz, M. (2020) · Journal of Cardiology and Cardiovascular Medicine · doi:10.29328/journal.jccm.1001091 · Cited by 2
“However, positively charged amino acids on the apolipoprotein B, and their interactions with the sulfate or carboxylate groups on the GAG chains are crucial for binding [104,105].”
BackgroundOwens, C. D., & Conte, M. S. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5223-4.00004-4 · Cited by 2
Pathogenesis of atherosclerosis: lipid metabolism
Wiklund, O., & Borén, J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755777.003.0011 · Cited by 3
Self-citationDu, J., Wang, Y., & Jia, L. (2015) · Atherosclerosis · doi:10.1002/9781118828533.ch27 · Cited by 2
Firth, C. A. (2006) · UC Research Repository (University of Canterbury) · doi:10.26021/6713 · Cited by 6
Actions of androgens and estrogens in experimental models of cardiovascular disease
Fagman, J. B. (2010) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 2
Genetics and molecular biology
Ikonen, E. (2005) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000194124.15216.e4 · Cited by 3
Apolipoprotein M – Studies of Structure and Function
Ahnström, J. (2009) · Lund University Publications (Lund University) · Cited by 2
Androgens: New Effects on Proteoglycan Biosynthesis and Its Consequences for Atherosclerosis
Sudhir, K., Nigro, J., Osman, N., & Little, P. J. (2005) · The Scientific World JOURNAL · doi:10.1100/tsw.2005.75 · Cited by 2
“One of the hypotheses of atherogenesis known as “Response to Retention”[15], which is based on the binding and retention of atherogenic lipoproteins, has recently risen to prominence[16,17].”
BackgroundArterial Zones That Take a Pause in Early Plaque Development
Williams, K. J. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319302 · Cited by 2
IgG Propels Atherosclerosis by Noncanonically Activating MacrophagesPreprint
Zahr, T., Zhang, K., Huang, S., Xue, C., Yu, L., Yu, Z., Li, B., Liang, D., Wang, Q., Shadrina, M., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.13.711718 · Cited by 2
Zhu, Q., Tan, Y., Zou, X., & Lu, L. (2023) · Scientific Reports · doi:10.1038/s41598-023-49771-1 · Cited by 1
Bao, X., Yin, S., Xu, B., Johnson, L., & Engström, G. (2026) · Circulation Population Health and Outcomes · doi:10.1161/circoutcomes.125.012505 · Cited by 1
Rare-Earth Nanomaterials for Advanced Theranostics of Atherosclerosis
Bai, Q., Ma, W., Zhao, F., AL-Ammari, A., Guan, S., Kang, B., Tian, X. Y., & Zhang, L. (2026) · Chemical & Biomedical Imaging · doi:10.1021/cbmi.5c00284 · Cited by 1
Enabling Technologies in Vascular Biology: Microphysiological Systems, Organoids, and Beyond
Gholizadeh, H., & Benam, K. H. (2026) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.126.323054 · Cited by 1
Cao, X., Mu, C., & Xu, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1903006 · Cited by 1
“Experimental disruption of ApoB – proteoglycan binding has been shown to markedly reduce early atherosclerotic lesion formation (4).”
Medical and Revascularization Management of Stable Ischemic Heart Disease: An Overview
Radaideh, Q., Shammas, N. W., Daher, G. E., & Rachwan, R. J. (2021) · International Journal of Angiology · doi:10.1055/s-0040-1722739 · Cited by 1
PRODUÇÃO E APLICAÇÃO DE SOFOROLIPÍDIOS EM COSMÉTICOS
Filipe, G. A., Lonni, A. A. S. G., & Celligoi, M. A. P. C. (2021) · doi:10.22533/at.ed.54721010414 · Cited by 2
Xu, Z., Yang, H., Wang, Q., Chen, H., Ma, C., Gao, Y., Li, H., & Zhang, X. (2026) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2026.104861 · Cited by 1
The response-to-retention hypothesis: From theory to the potential therapeutic approaches
Delgado-Roche, L. (2014) · Biomedicine & Aging Pathology · doi:10.1016/j.biomag.2014.08.001 · Cited by 2
Role of the Immunological System in the Initiation and Progression of Atherosclerosis
Roche, L. D. (2010) · Cited by 1
Molecular Biology and Genetics of Atherosclerosis
Hopkins, P. N. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1366-4.00008-1 · Cited by 1
Chatzantoni, K., & Mouzaki, Α. (2009) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195326697.003.0014 · Cited by 2
Chaves, J. D. O., de Oliveira, K. M., Figueiredo, L. S., Aguiar, G. D. S., Freitas, I. N., de Oliveira, C. D. A. R., Rios, V. K., Ribeiro, R. A., & Blanc, H. N. H. (2021) · doi:10.22533/at.ed.5472101043 · Cited by 2
Genetics and molecular biology
Ikonen, E. (2003) · Current Opinion in Lipidology · doi:10.1097/00041433-200304000-00014 · Cited by 3
Xu, R., Li, T., Li, Z., Kong, W., Wang, T., Zhang, X., Luo, J., Li, W., & Jiao, L. (2023) · European journal of medical research · doi:10.1186/s40001-023-01259-4 · Cited by 1
“Plasma-derived lipoproteins are retained as a result of this interaction [32, 33].”
BackgroundKnowledge mapping of B cell and atherosclerosis over the past 20 years: A bibliometric analysis
Cheng, T., You, Y., Jia, B., Wang, H., Lv, M., Zhu, X., & Hu, Y. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2277567 · Cited by 1
“It is generally believed that AS is a lipoprotein-driven disease, 6 and the accumulation of oxidized low-density lipoprotein (LDL) in the intima of the artery gradually forms atherosclerotic plaques, so reducing the level of LDL lipoprotein is the main strategy for the treatment of AS.”
Cui, J., Zhang, Y., Zhang, W., Li, D., Hong, Z., Zhao, L., Sun, J., Chen, Y., & Zhang, N. (2024) · Molecular Biotechnology · doi:10.1007/s12033-024-01218-2 · Cited by 3
“Other researchers have studied the heterogeneity LDL [41] and the affinity between lipoproteins and arterial walls [42], proposing treatment and prevention programs from the perspective of pathological mechanisms.”
L., J., C., S., & Taylor, R. L. (2013) · InTech eBooks · doi:10.5772/52948 · Cited by 1
“Electrostatic interac‐ tion between the LDL apoB and the sulfated chains on the core PG protein binds the LDL to the cell surface [18] where its solubility is decreased [19].”
BackgroundGlycosaminoglycans in Atherosclerosis and Thrombosis
Vicente, C. P., de Godoy, J. A. P., & WERNECK, C. C. (2011) · Springer eBooks · doi:10.1007/978-3-642-16833-8_4 · Cited by 1
Pathogenesis of Atherosclerotic Vascular Disease
Basha, B. J., Bakris, G. L., & Sowers, J. R. (2005) · Humana Press eBooks · doi:10.1385/1-59259-881-1:099 · Cited by 1
MULTISPECTRAL CONCURRENT DETECTION OF MULTIPLE PROTEINS
Chai, J., & Song, Q. (2012) · Nano LIFE · doi:10.1142/s1793984412410048 · Cited by 1
Cardiovascular complications of obesity and weight loss: pathogenesis and clinical recognition
Poirier, P. (2006) · Hot Topics in Cardiology · doi:10.4147/htc-060200 · Cited by 5
Pelosi, G. (2014) · Journal of Cytology & Histology · doi:10.4172/2157-7099.1000270 · Cited by 1
“Atherosclerosis (ATS) is a chronic inflammatory process of large and medium-size arteries, in which the focal endothelial activation, induced by hypercholesterolemia and lipoproteins deposition in the arterial intima, represents an essential initiating event [1,2].”
BackgroundKlimis‐Zacas, D. J., & Kristo, A. S. (2012) · ACS symposium series · doi:10.1021/bk-2012-1093.ch009 · Cited by 2
17. Cellular cholesterol retention in atherosclerosis
El‐Sayyad, H. I. (2016) · Wageningen Academic Publishers eBooks · doi:10.3920/978-90-8686-821-6_17 · Cited by 1
Metadata
- Authors
- Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J.
- Affiliations
- University of Gothenburg (SE)
- Gladstone Institutes (US)
- Corresponding author
- Borén, Jan
- Venue
- Nature
- Published
- 2002-06
- Volume
- 417
- Issue
- 6890
- Pages
- 750-754
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2083154566
- Cited by
- 1,019
- References
- 28
- Citations by year
- 2026: 23 · 2025: 28 · 2024: 38 · 2023: 42 · 2022: 41 · 2021: 69 · 2020: 48 · 2019: 39 · 2018: 39 · 2017: 29 · 2016: 27 · 2015: 46 · 2014: 42 · 2013: 42 · 2012: 63
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- American Heart Association
- Research to Prevent Blindness
- Vetenskapsrådet
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- atherosclerosis, atherogenesis, apolipoprotein B, apolipoprotein B-100, low-density lipoprotein, proteoglycans, extracellular matrix, sulfate groups, transgenic mice, atherogenic lipoproteins
- MeSH terms
- Animals, Aorta, Apolipoproteins B, Arteriosclerosis, Binding, Competitive, Cholesterol, Diet, Atherogenic, Endothelium, Vascular, Female, Humans, Lipoproteins, Lipoproteins, LDL, Macrophages, Mice, Transgenic, Models, Biological, Mutation, Receptors, LDL, Recombinant Proteins, Triglycerides, Tumor Necrosis Factor-alpha, Amino Acid Substitution, Mice, Apolipoprotein B-100
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.